Articles in Scholarly Journals [Incomplete List]

1. Investigation on the early events of apoptosis in senescent erythrocytes with special emphasis on intracellular free calcium and loss of phospholipid asymmetry in chronic renal failure
   Clinica Chimica Acta, vol. 382, no. 1-2, pp. 1–7, 2007
2. Beneficial role of sulfated polysaccharides from edible seaweed Fucus vesiculosus in experimental hyperoxaluria
   Food Chemistry, vol. 100, no. 4, pp. 1552–1559, 2007
3. Protective effect of lupeol and its ester on cardiac abnormalities in experimental hypercholesterolemia
   Vascular Pharmacology, vol. 46, no. 6, pp. 412–418, 2007
4. Physico-chemical alterations of urine in experimental hyperoxaluria: a biochemical approach with fucoidan
   Journal of Pharmacy and Pharmacology, vol. 59, no. 3, pp. 419–427, 2007
5. Lupeol and Its Ester Exhibit Protective Role Against Cyclophosphamide-Induced Cardiac Mitochondrial Toxicity
   Journal of Cardiovascular Pharmacology, vol. 47, no. 2, pp. 205–210, 2006
6. Chemoprotective effect of lipoic acid against cyclophosphamide-induced changes in the rat sperm
   Toxicology, vol. 217, no. 1, pp. 71–78, 2006
7. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity
   Toxicology, vol. 217, no. 2-3, pp. 176–183, 2006
8. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative
   International Journal of Cardiology, vol. 106, no. 3, pp. 338–347, 2006
9. Lipoic acid modulates adriamycin-induced testicular toxicity
   Reproductive Toxicology, vol. 21, no. 1, pp. 54–59, 2006
10. Protective effect of dl-α-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy
    European Journal of Pharmacology, vol. 543, no. 1-3, pp. 92–96, 2006
11. Role of lupeol and lupeol linoleate on lipemicâ??oxidative stress in experimental hypercholesterolemia
    Life Sciences, vol. 78, no. 12, pp. 1329–1335, 2006
12. Renal peroxidative changes mediated by oxalate: The protective role of fucoidan
    Life Sciences, vol. 79, no. 19, pp. 1789–1795, 2006
13. Oxidative renal injury and lipoprotein oxidation in hypercholesterolemic atherogenesis: Role of eicosapentaenoate-lipoate (EPA-LA) derivativeâ??
    Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 75, no. 1, pp. 25–31, 2006
14. Modulatory role of lipoic acid on adriamycin-induced testicular injury
    Chemico-Biological Interactions, vol. 160, no. 2, pp. 108–114, 2006
15. Suppressive effect of Withania somnifera root powder on experimental gouty arthritis: An in vivo and in vitro study
    Chemico-Biological Interactions, vol. 164, no. 3, pp. 174–180, 2006
16. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein
    Clinica Chimica Acta, vol. 364, no. 1-2, pp. 267–274, 2006
17. Protective effect of lipoic acid on cyclophosphamide-induced testicular toxicity
    Clinica Chimica Acta, vol. 367, no. 1-2, pp. 114–119, 2006
18. Low molecular weight heparin protection against oxalate-induced oxidative renal insult
    Clinica Chimica Acta, vol. 370, no. 1-2, pp. 108–114, 2006
19. Role of lipoic acid in reducing the oxidative stress induced by cyclosporine A
    Clinica Chimica Acta, vol. 372, no. 1-2, pp. 134–139, 2006
20. Oxalate mediated nephronal impairment and its inhibition by c-phycocyanin: A study on urolithic rats
    Molecular and Cellular Biochemistry, vol. 284, no. 1-2, pp. 95–101, 2006
21. Evaluating the Effect of Sulphated Polysaccharides on Cyclosporine A Induced Oxidative Renal Injury
    Molecular and Cellular Biochemistry, vol. 287, no. 1-2, pp. 101–108, 2006
22. Lupeol and its ester ameliorate the cyclophosphamide provoked cardiac lysosomal damage studied in rat
    Molecular and Cellular Biochemistry, vol. 282, no. 1-2, pp. 23–29, 2006
23. Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats
    Molecular and Cellular Biochemistry, vol. 292, no. 1-2, pp. 39–44, 2006
24. Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis
    Atherosclerosis, vol. 189, no. 1, pp. 115–122, 2006
25. Effect of lupeol and lupeol linoleate on lipemic â?? hepatocellular aberrations in rats fed a high cholesterol diet
    Molecular Nutrition & Food Research, vol. 50, no. 12, pp. 1212–1219, 2006
26. Protective role of sulphated polysaccharides in abating the hyperlipidemic nephropathy provoked by cyclosporine A
    Archives of Toxicology, vol. 81, no. 5, pp. 371–379, 2006
27. Detection of endothelial nitric oxide synthase and NADPH-diaphorase in experimentally induced hyperoxaluric animals
    Urological Research, vol. 33, no. 4, pp. 301–308, 2005
28. Cytoprotective role of DL-α-Lipoic acid in cyclophosphamide induced myocardial toxicity
    Molecular and Cellular Biochemistry, vol. 276, no. 1-2, pp. 39–44, 2005
29. Mitigation of oxidative stress in cyclophosphamide-challenged hepatic tissue by DL-α-lipoic acid
    Molecular and Cellular Biochemistry, vol. 272, no. 1-2, pp. 179–185, 2005
30. Protective effect of lipoic acid on micronuclei induction by cyclophosphamide
    Archives of Toxicology, vol. 80, no. 2, pp. 115–119, 2005
31. Beneficial effects of -?-lipoic acid on cyclophosphamide-induced oxidative stress in mitochondrial fractions of rat testis
    Chemico-Biological Interactions, vol. 152, no. 1, pp. 59–66, 2005
32. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment
    Chemico-Biological Interactions, vol. 156, no. 2-3, pp. 93–100, 2005
33. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers
    Clinica Chimica Acta, vol. 353, no. 1-2, pp. 45–51, 2005
34. Counteraction of oxalate induced nitrosative stress by supplementation of -arginine, a potent antilithic agent
    Clinica Chimica Acta, vol. 354, no. 1-2, pp. 159–166, 2005
35. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats
    Clinica Chimica Acta, vol. 355, no. 1-2, pp. 119–130, 2005
36. Attenuation of serum lipid abnormalities and cardiac oxidative stress by eicosapentaenoate?lipoate (EPA?LA) derivative in experimental hypercholesterolemia
    Clinica Chimica Acta, vol. 355, no. 1-2, pp. 197–204, 2005
37. Oral -arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tammâ??Horsfall glycoprotein in experimental hyperoxaluric rats
    Clinica Chimica Acta, vol. 360, no. 1-2, pp. 141–150, 2005
38. Protective effect of lipoic acid on adriamycin-induced testicular toxicity
    Clinica Chimica Acta, vol. 360, no. 1-2, pp. 160–166, 2005
39. Credentials of diet on stability and flux related properties on the biomineralization process during oxalate mediated renal calcification in rats
    Clinical Nutrition, vol. 24, no. 6, pp. 932–942, 2005
40. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities
    Toxicology, vol. 211, no. 1-2, pp. 77–85, 2005
41. -α-lipoic acid ameliorates cyclophosphamide induced cardiac mitochondrial injury
    Toxicology, vol. 215, no. 1-2, pp. 108–114, 2005
42. Lipoic acid ameliorates adriamycin-induced testicular mitochondriopathy
    Reproductive Toxicology, vol. 20, no. 1, pp. 111–116, 2005
43. Structural and Functional Modification of THP on Nitration: Comparison with Stone Formers THP
    Nephron Physiology, vol. 99, no. 1, pp. p28–p34, 2005
44. Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients
    Nephrology Dialysis Transplantation, vol. 20, no. 7, pp. 1407–1415, 2005
45. Counteracting adriamycin-induced oxidative stress by administration of N-acetyl cysteine and vitamin E
    Clinical Chemistry and Laboratory Medicine, vol. 43, no. 8, pp. 834–840, 2005
46. Cardioprotective effect of pentacyclic triterpene, lupeol and its ester on cyclophosphamide-induced oxidative stress
    Human & Experimental Toxicology, vol. 24, no. 6, pp. 313–318, 2005
47. Salubrious Effect of Vitamin E Supplementation on Renal Stone Forming Risk Factors in Urogenital Tuberculosis Patients
    Renal Failure, vol. 26, no. 2, pp. 135–140, 2004
48. Remedial effect of DL- -lipoic acid against adriamycin induced testicular lipid peroxidation
    Molecular and Cellular Biochemistry, vol. 267, no. 1/2, pp. 209–214, 2004
49. Modulatory Effect of the 23-kD Calcium Oxalate Monohydrate Binding Protein on Calcium Oxalate Stone Formation during Oxalate Stress
    Nephron Physiology, vol. 97, no. 1, pp. p23–p30, 2004
50. Expression of Nuclear Pore Complex Oxalate Binding Protein p62 in Experimental Hyperoxaluria
    Nephron Experimental Nephrology, vol. 97, no. 3, pp. e106–e114, 2004
51. Combined efficacies of lipoic acid and 2,3-dimercaptosuccinic acid against lead-induced lipid peroxidation in rat liver
    The Journal of Nutritional Biochemistry, vol. 15, no. 1, pp. 18–23, 2004
52. Protective effect of -?-lipoic acid in cyclophosphamide induced oxidative injury in rat testis
    Reproductive Toxicology, vol. 19, no. 2, pp. 163–167, 2004
53. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers
    Urological Research, vol. 32, no. 5, pp. 357–361, 2004
54. Therapeutic efficacy of lipoic acid in combination with dimercaptosuccinic acid against lead-induced renal tubular defects and on isolated brush-border enzyme activities
    Chemico-Biological Interactions, vol. 147, no. 3, pp. 259–271, 2004
55. Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injury
    Chemico-Biological Interactions, vol. 149, no. 1, pp. 1–7, 2004
56. Protective effect of -?-lipoic acid on cyclophosphamide induced oxidative cardiac injury
    Chemico-Biological Interactions, vol. 151, no. 1, pp. 13–19, 2004
57. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis
    Clinica Chimica Acta, vol. 339, no. 1-2, pp. 105–115, 2004
58. Nuclear pore complex oxalate binding protein p62: expression in different kidney disorders
    Clinica Chimica Acta, vol. 347, no. 1-2, pp. 111–119, 2004
59. Salubrious effect of C-phycocyanin against oxalate-mediated renal cell injury
    Clinica Chimica Acta, vol. 348, no. 1-2, pp. 199–205, 2004
60. Oxidative stress in urogenital tuberculosis patients: a predisposing factor for renal stone formation?amelioration by vitamin E supplementation
    Clinica Chimica Acta, vol. 350, no. 1-2, pp. 57–63, 2004
61. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity
    Chemico-Biological Interactions, vol. 146, no. 2, pp. 201–210, 2003
62. The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity
    European Journal of Pharmacology, vol. 478, no. 2-3, pp. 199–205, 2003
63. Lipoic acid as a rescue agent for adriamycin-induced hyperlipidemic nephropathy in rats
    Nutrition Research, vol. 23, no. 4, pp. 539–548, 2003
64. Molecular and Cellular Biochemistry, vol. 247, no. 1/2, pp. 15–22, 2003
65. Molecular and Cellular Biochemistry, vol. 248, no. 1/2, pp. 35–40, 2003
66. Molecular and Cellular Biochemistry, vol. 247, no. 1/2, pp. 9–13, 2003
67. Molecular and Cellular Biochemistry, vol. 247, no. 1/2, pp. 139–145, 2003
68. Molecular and Cellular Biochemistry, vol. 254, no. 1/2, pp. 111–116, 2003
69. Prophylactic Effect of Lipoic Acid Against Adriamycin-Induced Peroxidative Damages in Rat Kidney
    Renal Failure, vol. 25, no. 3, pp. 367–377, 2003
70. Combined efficacies of lipoic acid and meso-2,3-dimercaptosuccinic acid on lead-induced erythrocyte membrane lipid peroxidation and antioxidant status in rats
    Human & Experimental Toxicology, vol. 22, no. 4, pp. 183–192, 2003
71. Favourable influence of low molecular weight heparin in mitigating the peroxidative membrane damage induced by a cytotoxic agent and an atherogenic diet
    Human & Experimental Toxicology, vol. 22, no. 5, pp. 229–235, 2003
72. Protective role of DLa-lipoic acid against adriamycin-induced cardiac lipid peroxidation
    Human & Experimental Toxicology, vol. 22, no. 5, pp. 249–254, 2003
73. Mitigation of free radical toxicity in hyperoxaluric condition by a novel derivative eicosapentaenoate-lipoate
    Human & Experimental Toxicology, vol. 21, no. 3, pp. 153–158, 2002
74. Lipoic acid in combination with a chelator ameliorates lead-induced peroxidative damages in rat kidney
    Archives of Toxicology, vol. 76, no. 8, pp. 437–441, 2002
75. Evaluation of the effect of triterpenes on urinary risk factors of stone formation in pyridoxine deficient hyperoxaluric rats
    Phytotherapy Research, vol. 16, no. 6, pp. 514–518, 2002
76. Effect of lupeol, a pentacyclic triterpene, on the lipid peroxidation and antioxidant status in rat kidney after chronic cadmium exposure
    Journal of Applied Toxicology, vol. 20, no. 5, pp. 413–417, 2000
77. Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria
    Fitoterapia, vol. 71, no. 5, pp. 535–543, 2000
78. Anticomplement activity of triterpenes from Crataeva nurvala stem bark in adjuvant arthritis in rats
    General Pharmacology: The Vascular System, vol. 32, no. 4, pp. 495–497, 1999
79. Activities of glucose-metabolizing enzymes in experimental neurotoxic models with lipoate as an alleviator
    Journal of Applied Toxicology, vol. 19, no. 6, pp. 405–409, 1999
80. PROTECTIVE ROLE OF?-a-LIPOIC ACID AGAINST MERCURY-INDUCED NEURAL LIPID PEROXIDATION
    Pharmacological Research, vol. 39, no. 1, pp. 67–80, 1999
81. EFFECT OF TRITERPENES FROMCRATAEVA NURVALASTEM BARK ON LIPID PEROXIDATION IN ADJUVANT INDUCED ARTHRITIS IN RATS
    Pharmacological Research, vol. 37, no. 3, pp. 191–195, 1998
82. Effect of Vernonia cinerea Less Flower Extract in Adjuvant-Induced Arthritis
    General Pharmacology: The Vascular System, vol. 31, no. 4, pp. 601–606, 1998
83. Effect of lipoic acid administration on gentamicin-induced lipid peroxidation in rats
    Journal of Applied Toxicology, vol. 17, no. 6, pp. 405–408, 1997
84. Altered physicochemical characteristics of polyethylene glycol linked beet stem oxalate oxidase
    Biotechnology and Bioengineering, vol. 46, no. 3, pp. 254–257, 1995
85. Impaired lipid metabolism in calcium oxalate stone forming rats and DL a - lipoic acid supplementation
    Nutrition Research, vol. 15, no. 1, pp. 59–70, 1995
86. Effect of L-cysteine on lipid peroxidation in experimental urolithiatic rats
    Pharmacological Research, vol. 32, no. 3, pp. 165–169, 1995
87. Effect of Sodium Pentosan Polysulphate on Tissue Lipids in Control and Glycollate Treated Rats
    Pharmacological Research, vol. 27, no. 4, pp. 289–298, 1993
88. Effect of DL a-Lipoic Acid on Tissue Lipid Peroxidation and Antioxidant Systems in Normal and Glycollate Treated Rats
    Pharmacological Research, vol. 27, no. 4, pp. 309–318, 1993
89. Effect of Crataeva nurvala in experimental urolithiasis
    Journal of Ethnopharmacology, vol. 28, no. 3, pp. 313–321, 1990
90. The effects of vitamin B-6 deficiency and hepatectomy on the synthesis of oxalate from glycolate in the rat
    Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 757, no. 1, pp. 1–7, 1983